Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

EU-owned institutions including the EIF are pouring capital and assistance into an early-stage tech transfer vehicle for the Fraunhofer network of applied research institutes.

Fintech developer Nivaura has closed its seed round at $20m after closing a third tranche, with the capital coming from investors including London Stock Exchange, Transamerica, Santander, Linklaters and Orrick.

Karolinska Institute’s oncology spinout Aprea Therapeutics has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

Praktikertjänst-backed oncology company Aprea has received a $5.7m series C extension adding to an initial $56.8m close in November 2018 that featured Karolinska Development.

MS&AD Ventures has contributed to a round for i2x, which offers an enhanced speech recognition product that provides automated coaching tips to improve business phone calls.

Unternehmertum’s VC affiliate co-led the deal for i2x, which offers an enhanced speech recognition product that provides automated coaching tips to improve business phone calls.

Touchstone Innovations-backed Cambridge Communication System has received $10m in a funding round that included a $5m commitment from Adtran.

University of Birmingham and Aston University have deepened their relationship with Warwick-operated Minerva to start a syndicate targeting businesses in the West Midlands.